In the present study, patients with baseline AFP ≥ 400 ng/mL had significantly poorer overall survival compared with those with AFP < 400 ng/mL, which is consistent with previous reports (30), suggesting that elevated AFP is closely associated with unfavorable long-term prognosis in patients with hepatocellular carcinoma. This evidence concerns the gene AFP and hepatocellular carcinoma.